-
1
المؤلفون: David M. Loeb, Ji Won Lee, Daniel A. Morgenstern, Yvan Samson, Anne Uyttebroeck, Chuhl Joo Lyu, An Van Damme, Karsten Nysom, Margaret E. Macy, Alexandra P. Zorzi, Julia Xiong, Petra Pollert, Ingrid Joerg, Yulia Vugmeyster, Mary Ruisi, Hyoung Jin Kang
المصدر: Paediatrics Publications
مصطلحات موضوعية: Cancer Research, Avelumab, Science & Technology, Immunology, MULTICENTER, Paediatrics, Immune checkpoint inhibitor, Phase 1, Antibodies, Monoclonal, Humanized, Cohort Studies, Oncology, Neoplasms, Humans, Immunology and Allergy, Immunotherapy, Child, Life Sciences & Biomedicine, Fatigue
وصف الملف: application/pdf; Print-Electronic
-
2Academic Journal
المؤلفون: Job, Harenberg, Ingrid, Jörg, Tivadar, Fenyvesi, Lukas, Piazolo
المصدر: Journal of Thrombosis and Thrombolysis ; volume 20, issue 2, page 137-137 ; ISSN 0929-5305 1573-742X
-
3
المؤلفون: Job Harenberg, T. Fenyvesi, Ingrid Joerg
المصدر: Europe PubMed Central
مصطلحات موضوعية: Benzylamines, medicine.drug_class, Clinical Biochemistry, Glycine, Hirudin, Administration, Oral, Pharmacology, Arginine, Argatroban, medicine, Humans, Prothrombin time, Sulfonamides, medicine.diagnostic_test, business.industry, Biochemistry (medical), Anticoagulant, Anticoagulants, Drug Synergism, Hirudins, Lepirudin, medicine.disease, Recombinant Proteins, Venous thrombosis, Coagulation, Pipecolic Acids, Anesthesia, Phenprocoumon, Prothrombin Time, Azetidines, business, medicine.drug, Discovery and development of direct thrombin inhibitors
-
4Academic Journal
المؤلفون: M.D Job Harenberg, M.D Tivadar Fenyvesi, M.D Ingrid Jörg
المساهمون: The Pennsylvania State University CiteSeerX Archives
وصف الملف: application/pdf
Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1054.6030; http://prof-harenberg.de/Web/prof-harenberg.de/Publikation%20pdf/Messmethod%20von%20Antikoagulantien/Thrombininhibitoren,%20Nachweise.pdf
-
5Academic Journal
المؤلفون: Tivadar Fenyvesi, Ingrid Joerg
المساهمون: The Pennsylvania State University CiteSeerX Archives
وصف الملف: application/pdf
Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.486.7837; http://www.clinchem.org/content/48/10/1791.full.pdf
-
6
المؤلفون: Antje Hagedorn, Christina Giese, Ingrid Joerg, Job Harenberg
المصدر: Blood. 110:1877-1877
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Idraparinux, Immunology, Warfarin, Cell Biology, Hematology, Heparin, Biochemistry, Surgery, Nadroparin, Antithrombotic, medicine, cardiovascular diseases, Factor V Leiden mutation, business, Adverse effect, Venous thromboembolism, medicine.drug
-
7
المؤلفون: Ingrid Joerg, Christina Giese, Gerd Mikus, Job Harenberg, Christel Weiss, Antje Hagedorn
المصدر: Blood. 110:1883-1883
مصطلحات موضوعية: business.industry, medicine.drug_class, Idraparinux, Immunology, Antithrombin, Anticoagulant, Warfarin, Renal function, Cell Biology, Hematology, Placebo, Biochemistry, Pharmacodynamics, Anesthesia, Medicine, Biological half-life, business, medicine.drug
-
8
المؤلفون: Job Harenberg, T. Fenyvesi, Christel Weiss, Ingrid Joerg
المصدر: Blood. 108:899-899
مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.drug_class, Idraparinux, Immunology, Anticoagulant, Warfarin, Renal function, Cell Biology, Hematology, Placebo, Biochemistry, Surgery, Coagulation, Clotting time, Anesthesia, Antithrombotic, Medicine, business, medicine.drug
-
9Academic Journal
المساهمون: David M Loeb, Ji Won Lee, Daniel A Morgenstern, Yvan Samson, Anne Uyttebroeck, Chuhl Joo Lyu, An Van Damme, Karsten Nysom, Margaret E Macy, Alexandra P Zorzi, Julia Xiong, Petra Pollert, Ingrid Joerg, Yulia Vugmeyster, Mary Ruisi, Hyoung Jin Kang, Lyu, Chuhl Joo
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized* / adverse effects, Child, Cohort Studies, Fatigue, Humans, Neoplasms* / drug therapy, Neoplasms* / pathology, Avelumab, Immune checkpoint inhibitor, Immunotherapy, Paediatrics, Phase 1
Relation: CANCER IMMUNOLOGY IMMUNOTHERAPY; J00445; OAK-2022-09241; https://ir.ymlib.yonsei.ac.kr/handle/22282913/192857; T202205961; CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.71(10) : 2485-2495, 2022-10